Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angharad G Davis, Dr
1. Faculty of Life Sciences, University College London, UK 2. Department of Medicine, University of Cape Town, Observatory 7925, Republic of South Africa
Study Chair - Graeme Meintjes, PhD
Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Principal Investigator - John Black, MBChB
Department of Medicine, University of Cape Town and Walter Sisal University
Principal Investigator - Robert J Wilkinson, PhD
Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Principal Investigator - Sean Wasserman, MMed
Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Livingstone Hospital
Port Elizabeth, Eastern Cape, South Africa
- Groote Schuur Hospital
Cape Town, Western Cape, South Africa
- Mitchells Plain Hospital
Cape Town, Western Cape, South Africa
- New Somerset Hospital
Cape Town, Western Cape, South Africa
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jun 2019
- Primary completion
- 30 Mar 2021
- Completion
- 31 Mar 2021
- Last update posted
- 28 Sept 2021
- Registered enrollment
- 52
- Registry id
- NCT03927313
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.